2-[1-[2-[(1-cyclopropylpyrazol-4-yl)amino]-5-methylpyrimidin-4-yl]-3-(4-fluoropiperidin-1-yl)azetidin-3-yl]acetonitrile

C21H27FN8 — CID 176723725

IUPAC2-[1-[2-[(1-cyclopropylpyrazol-4-yl)amino]-5-methylpyrimidin-4-yl]-3-(4-fluoropiperidin-1-yl)azetidin-3-yl]acetonitrile
SMILESCc1cnc(Nc2cnn(C3CC3)c2)nc1N1CC(CC#N)(N2CCC(F)CC2)C1
InChIInChI=1S/C21H27FN8/c1-15-10-24-20(26-17-11-25-30(12-17)18-2-3-18)27-19(15)28-13-21(14-28,6-7-23)29-8-4-16(22)5-9-29/h10-12,16,18H,2-6,8-9,13-14H2,1H3,(H,24,26,27)
InChIKeyVDDMOJKELQRUMP-UHFFFAOYSA-N
MW410.50 g/mol
LogP2.97
Rot. Bonds6

About 2-[1-[2-[(1-cyclopropylpyrazol-4-yl)amino]-5-methylpyrimidin-4-yl]-3-(4-fluoropiperidin-1-yl)azetidin-3-yl]acetonitrile

2-[1-[2-[(1-cyclopropylpyrazol-4-yl)amino]-5-methylpyrimidin-4-yl]-3-(4-fluoropiperidin-1-yl)azetidin-3-yl]acetonitrile (PubChem CID 176723725) has the molecular formula C21H27FN8 and a molecular weight of 410.50 g/mol. Its IUPAC name is 2-[1-[2-[(1-cyclopropylpyrazol-4-yl)amino]-5-methylpyrimidin-4-yl]-3-(4-fluoropiperidin-1-yl)azetidin-3-yl]acetonitrile.

Molecular Properties

Compound Name2-[1-[2-[(1-cyclopropylpyrazol-4-yl)amino]-5-methylpyrimidin-4-yl]-3-(4-fluoropiperidin-1-yl)azetidin-3-yl]acetonitrile
PubChem CID176723725
Molecular FormulaC21H27FN8
Molecular Weight410.50 g/mol
Exact Mass410.23
IUPAC Name2-[1-[2-[(1-cyclopropylpyrazol-4-yl)amino]-5-methylpyrimidin-4-yl]-3-(4-fluoropiperidin-1-yl)azetidin-3-yl]acetonitrile
SMILESCc1cnc(Nc2cnn(C3CC3)c2)nc1N1CC(CC#N)(N2CCC(F)CC2)C1
InChIInChI=1S/C21H27FN8/c1-15-10-24-20(26-17-11-25-30(12-17)18-2-3-18)27-19(15)28-13-21(14-28,6-7-23)29-8-4-16(22)5-9-29/h10-12,16,18H,2-6,8-9,13-14H2,1H3,(H,24,26,27)
InChIKeyVDDMOJKELQRUMP-UHFFFAOYSA-N
XLogP2.97
TPSA85.90 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds6
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500410.50
LogP ≤ 52.97
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze 2-[1-[2-[(1-cyclopropylpyrazol-4-yl)amino]-5-methylpyrimidin-4-yl]-3-(4-fluoropiperidin-1-yl)azetidin-3-yl]acetonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[1-[2-[(1-cyclopropylpyrazol-4-yl)amino]-5-methylpyrimidin-4-yl]-3-(4-fluoropiperidin-1-yl)azetidin-3-yl]acetonitrile?
The IUPAC name of 2-[1-[2-[(1-cyclopropylpyrazol-4-yl)amino]-5-methylpyrimidin-4-yl]-3-(4-fluoropiperidin-1-yl)azetidin-3-yl]acetonitrile (CID 176723725) is 2-[1-[2-[(1-cyclopropylpyrazol-4-yl)amino]-5-methylpyrimidin-4-yl]-3-(4-fluoropiperidin-1-yl)azetidin-3-yl]acetonitrile.
What is the SMILES notation for 2-[1-[2-[(1-cyclopropylpyrazol-4-yl)amino]-5-methylpyrimidin-4-yl]-3-(4-fluoropiperidin-1-yl)azetidin-3-yl]acetonitrile?
The canonical SMILES for 2-[1-[2-[(1-cyclopropylpyrazol-4-yl)amino]-5-methylpyrimidin-4-yl]-3-(4-fluoropiperidin-1-yl)azetidin-3-yl]acetonitrile is Cc1cnc(Nc2cnn(C3CC3)c2)nc1N1CC(CC#N)(N2CCC(F)CC2)C1.
What is the InChIKey of 2-[1-[2-[(1-cyclopropylpyrazol-4-yl)amino]-5-methylpyrimidin-4-yl]-3-(4-fluoropiperidin-1-yl)azetidin-3-yl]acetonitrile?
The InChIKey is VDDMOJKELQRUMP-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H27FN8/c1-15-10-24-20(26-17-11-25-30(12-17)18-2-3-18)27-19(15)28-13-21(14-28,6-7-23)29-8-4-16(22)5-9-29/h10-12,16,18H,2-6,8-9,13-14H2,1H3,(H,24,26,27).
What are the key properties of 2-[1-[2-[(1-cyclopropylpyrazol-4-yl)amino]-5-methylpyrimidin-4-yl]-3-(4-fluoropiperidin-1-yl)azetidin-3-yl]acetonitrile?
2-[1-[2-[(1-cyclopropylpyrazol-4-yl)amino]-5-methylpyrimidin-4-yl]-3-(4-fluoropiperidin-1-yl)azetidin-3-yl]acetonitrile has a molecular weight of 410.50 g/mol, XLogP of 2.97, 6 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[1-[2-[(1-cyclopropylpyrazol-4-yl)amino]-5-methylpyrimidin-4-yl]-3-(4-fluoropiperidin-1-yl)azetidin-3-yl]acetonitrile is sourced from PubChem (CID 176723725), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).